The clinical spectrum of MASLD spans from simple steatosis, which is often benign and potentially reversible, to metabolic dysfunction-associated steatohepatitis (MASH), a progressive and inflammatory condition that may lead to hepatic fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) (2, 3)
Every participant in the 12mg group lost at least 5% of body weight
This makes it potentially more effective than dual agonists like tirzepatide
In the 1950s, bodybuilder and nutritionist Bob Hoffman revolutionized the industry with his chocolate-flavored Hi-Proteen supplements marketed to athletes, and in the 1970s, the weight-loss industry popularized protein shakes as meal replacements
Related articles Stuck in a Rut
No planning, no shopping, no guessing